Direxion Daily S&P Biotech Bull 3X Shares · $577M$2,639
LABULABU vsIVVIVViShares Core S&P 500 ETF · $872B$18,118
$10,000 five years ago, dividends reinvested · they hold 1.6% in common
LABUMeasureIVV
Returns · dividends reinvested
+63.5%Year to dateJan 1 → Nov 4+13.4%
+116.6%1 yearTotal return+13.5%
+72.3%3 years · per year$10,000 became $51,144 · $19,178+24.2%
−23.4%5 years · per year$10,000 became $2,639 · $18,118+12.6%
Cost and income
0.96%Expense ratio$96 · $3 a year on $10k · lower is better0.03%
0.35%Trailing 12-mo yield$35 · $109 a year on $10k1.09%
Risk · past year
−41.8%Worst dropSmaller is better−8.9%
86.5%VolatilityLower is calmer12.9%
LABUIVV Winner of the row, in its colourEach row: the bigger of the two fills its side
3–5IVV wins
End-of-day Nov 4, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns